KANINA CROSEN: Open Payments
NPI 1346541273 · OXFORD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 19 payments from 7 companies in 2025. Trend: 2023 $884 · 2024 $402 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $113 |
| ABBVIE INC. | 4 | $69 |
| Lilly USA, LLC | 3 | $55 |
| PFIZER INC. | 2 | $45 |
| Exact Sciences Corporation | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Atland Pharmaceuticals, LLC | 1 | $17 |
Products named: Wegovy, VRAYLAR, MOUNJARO, NURTEC ODT, Cologuard Collection Kit, REXULTI, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE.
Industry payments across AL — which companies pay providers there.
